Skip to main content
SpringerLink
Log in

Erythrocyte lifespan as a proposed explanation for increased risk of malignancies among people with low HbA1c

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 31 October 2019

The Original Article was published on 09 August 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kobayashi D, Kuriyama N, Noto H, Aida A, Takahashi O, Shimbo T (2019) Development of malignancies and changes in time-dependent hemoglobin A1c among a nondiabetic population: longitudinal analysis. Acta Diabetol. https://doi.org/10.1007/s00592-019-01396-5

    Article  PubMed  Google Scholar 

  2. Kameyama M, Takeuchi S, Ishii S (2018) Steady-state relationship between average glucose, HbA1c and RBC lifespan. J Theor Biol 447:111–117. https://doi.org/10.1016/j.jtbi.2018.03.023

    Article  CAS  PubMed  Google Scholar 

  3. Ricks J, Molnar MZ, Kovesdy CP et al (2012) Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes 61:708–715. https://doi.org/10.2337/db11-1015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Inaba M, Okuno S, Kumeda Y et al (2007) Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18:896–903. https://doi.org/10.1681/ASN.2006070772

    Article  CAS  PubMed  Google Scholar 

  5. Freedman BI, Andries L, Shihabi ZK et al (2011) Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol 6:1635–1643. https://doi.org/10.2215/CJN.11491210

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Ms. Natalie Okawa for English language editing of this manuscript.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan

    Masashi Kameyama

  2. Department of Internal Medicine, Hakuhokai Central Hospital, Amagasaki, Japan

    Masafumi Koga

Authors
  1. Masashi Kameyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masafumi Koga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masashi Kameyama.

Ethics declarations

Conflict of interest

M. Kameyama received research fund from Nihon Medi-physics, and Fujifilm Toyama Chemistry.

Ethical standard

This article does not contain any studies with human or animal subjects performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Managed by Massimo Porta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kameyama, M., Koga, M. Erythrocyte lifespan as a proposed explanation for increased risk of malignancies among people with low HbA1c. Acta Diabetol 57, 499–500 (2020). https://doi.org/10.1007/s00592-019-01431-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-019-01431-5

Search

Navigation